The Victorian Government has announced that it will provide an extra $400,000 funding to extend the PrEPX HIV prevention medication study. The additional investment means the study will now run until 30 June 2018 – three months longer than its initial period.
This announcement comes in the wake of the PrEP medication recently being listed on the Pharmaceutical Benefits Scheme, making it more affordable and accessible. The extra funding is intended to allow Victorians to transition to accessing PrEP through their GP. The Government is working to develop resources for doctors and nurses to allow them to easily dispense PrEP immediately after the study ends.
Read the Government’s media release here.